Both in Pharmaceuticals
Rein Therapeutics vs Citius Oncology
Over the past year RNTX returned −45.9% and CTOR returned −66.9%; their daily moves had a correlation of 0.07.
RNTX −45.9% CTOR −66.9%Growth of $1, one year, split-adjusted
| Metric | RNTX | CTOR |
|---|---|---|
| Price | $0.7147 | $0.5768 |
| Market cap | $61.7M | $61.0M |
| Today | +1.49% | −5.60% |
| 1 month | −9.5% | −45.1% |
| 6 months | −43.9% | −32.9% |
| Year to date | −38.4% | −42.3% |
| 1 year | −47.1% | −66.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.6× |
| Net cash | $40.6M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | 101.6% |
| Short % of float | 2.6% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).